Open House Biologics Discount Agreements 2024-10 - Pertuzumab / Trastuzumab (Drug Combination)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 97577213

  Document Type - Tender Notices

Description - Description: The participating health insurance companies aim to conclude discount agreements with all suitable pharmaceutical companies in accordance with Section 130c Paragraph 1 of the Social Security Code (SGB V) for the active ingredient combina tion pertuzumab/trastuzumab. The contract is concluded as part of the open house biologics procedure of the participating health insurance companies:local title:: Open-House-Biologika-Rabattverträge 2024-10 - Pertuzumab / Trastuzumab (Wirkstoffkombination)local description: : Die beteiligten Kassen verfolgen das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zu der Wirkstoffkombination Pertuzum

Gt Ref Id - 97577213

Deadline - Dec 31, 2026